RYDAPT
RYDAPT
Approved
DIN Number
02466236
Drug Class
Human
Market Date
Sep 8, 2017
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02466236
AIG Number0159270001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX10 MIDOSTAURIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
MIDOSTAURINActive
Strength: 25 MG
Monograph: MIDOSTAURIN